Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | AMGN | GILD | VRTX | BIIB |
| Company | Reata Pharma | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 172.34 | 333.93 | 83.37 | 483.78 | 198.13 |
| High | 172.46 | 339.00 | 84.52 | 483.78 | 199.78 |
| Low | 172.32 | 331.00 | 82.76 | 476.06 | 196.81 |
| Last | 172.36 | 334.87 | 84.22 | 478.00 | 198.54 |
| Change | +0.04 | +2.07 | +1.17 | -3.26 | +0.33 |
| % Change | +0.02% | +0.62% | +1.41% | -0.68% | +0.17% |
| Volume | 1,988,500 | 770,575 | 6,107,040 | 448,151 | 366,601 |
| 20-Day Average Volume | 810,510 | 1,703,773 | 6,258,449 | 957,816 | 785,530 |
| Previous Close | 172.32 | 332.80 | 83.05 | 481.26 | 198.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 329.42 | 79.66 | 480.48 | 201.94 |
| 20-Day Raw Stochastic | 97.36% | 87.95% | 95.64% | 44.43% | 47.85% |
| 20-Day Relative Strength | 81.56% | 57.88% | 72.86% | 49.40% | 42.25% |
| Weighted Alpha | +177.60 | +27.34 | +19.31 | +33.68 | -22.61 |
| Today's Opinion | 100% Buy | 96% Buy | 88% Buy | 40% Buy | 100% Sell |
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | 56% Buy | 100% Sell |
| Last Month's Opinion | 100% Buy | 72% Buy | 40% Buy | 88% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | +1.95% since 09/11/24 | +4.34% since 09/11/24 | +0.74% since 09/11/24 | +0.25% since 09/11/24 |
| Low | 171.96 on 09/19/23 | 326.41 on 09/12/24 | 81.57 on 09/13/24 | 468.46 on 09/12/24 | 192.25 on 09/13/24 |
| High | 172.46 on 09/25/23 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 490.15 on 09/16/24 | 202.79 on 09/17/24 |
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | +4.66% since 08/16/24 | +14.46% since 08/16/24 | +0.19% since 08/16/24 | -1.15% since 08/16/24 |
| Low | 168.67 on 09/05/23 | 319.00 on 09/06/24 | 73.27 on 08/19/24 | 460.69 on 09/11/24 | 192.25 on 09/13/24 |
| High | 172.46 on 09/25/23 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | +9.94% since 06/18/24 | +33.73% since 06/18/24 | +2.35% since 06/18/24 | -10.76% since 06/18/24 |
| Low | 88.80 on 06/27/23 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 192.25 on 09/13/24 |
| High | 172.46 on 09/25/23 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | +24.18% since 03/18/24 | +15.27% since 03/18/24 | +16.26% since 03/18/24 | -9.03% since 03/18/24 |
| Low | 76.54 on 05/10/23 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 172.46 on 09/25/23 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 178,525,568 | 103,468,096 | 124,190,592 | 28,858,782 |
| Shares Outstanding, K | 38,150 | 536,435 | 1,245,853 | 258,053 | 145,597 |
| Annual Sales | 2,220,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -311,900,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 22,750,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 2,464,900,000 |
| Last Quarter Net Income | 193,000,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 583,600,000 |
| 60-Month Beta | 1.42 | 0.61 | 0.18 | 0.40 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 11/14/23 | 10/29/24 | 11/05/24 | 11/04/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.02 | 17.69 | 0.00 | 12.27 |